Bausch Health Companies (BHC) Change in Receivables (2009 - 2026)

Bausch Health Companies has disclosed Change in Receivables across 18 years of filings, most recently posting $70.0 million for Q2 2026.

• In Q2 2026, Change in Receivables fell 23.08% year-over-year to $70.0 million; the TTM figure through Jun 2026 stood at $75.0 million (up 20.97% YoY), while the FY2025 annual figure was $134.0 million, down 37.96% from the prior year.
• Change in Receivables came in at $70.0 million for Q2 2026 at Bausch Health Companies, up from -$148.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $231.0 million in Q3 2023 to a low of -$197.0 million in Q1 2022.
• Average Change in Receivables over 5 years is $29.1 million, with a median of $58.0 million recorded in 2023.
• The largest YoY upside for Change in Receivables was 1047.83% in 2025 against a maximum downside of 274.6% in 2025.
• Over 5 years, Change in Receivables stood at $31.0 million in 2022, then slumped by 38.71% to $19.0 million in 2023, then jumped by 447.37% to $104.0 million in 2024, then plunged by 162.5% to -$65.0 million in 2025, then surged by 207.69% to $70.0 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $70.0 million in Q2 2026, -$148.0 million in Q1 2026, and -$65.0 million in Q4 2025.